TREK1 Neurons
Introduction
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">TREK1 Neurons</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>KCNK2</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>TREK1 (TWIK-Related Potassium Channel 1)</td>
</tr>
<tr>
<td class="label">Channel Type</td>
<td>Two-pore domain potassium channel (K2P)</td>
</tr>
<tr>
<td class="label">Location</td>
<td>[Cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), thalamus, dorsal root ganglion, spinal cord</td>
</tr>
<tr>
<td class="label">Cell Types</td>
<td>Pyramidal neurons, interneurons, DRG neurons, [astrocytes](/entities/astrocytes)</td>
</tr>
<tr>
<td class="label">Primary Neurotransmitter</td>
<td>Depends on neuron type (glutamate, GABA)</td>
</tr>
<tr>
<td class="label">Key Markers</td>
<td>KCNK2, KCNK4 (TRAAK)</td>
</tr>
<tr>
<td class="label">Stimulus</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">Membrane stretch</td>
<td>Activation</td>
</tr>
<tr>
<td class="label">Temperature</td>
<td>Activation</td>
</tr>
<tr>
<td class="label">pH (acidosis)</td>
<td>Activation</td>
</tr>
<tr>
<td class="label">Volatile anesthetics</td>
<td>Activation</td>
</tr>
<tr>
<td class="label">Voltage</td>
<td>Weak voltage dependence</td>
</tr>
<tr>
<td class="label">Phosphorylation</td>
<td>Modulation</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Compound</td>
</tr>
<tr>
<td class="label">Activators</td>
<td>ML335, ML335</td>
</tr>
<tr>
<td class="label">Activators</td>
<td>Volatile anesthetics</td>
</tr>
<tr>
<td class="label">Inhibitors</td>
<td>Spadin</td>
</tr>
</table>
TREK1 (TWIK-Related Potassium Channel 1), encoded by the KCNK2 gene, is a member of the two-pore domain potassium (K2P) channel family. These channels provide background leak potassium conductance that regulates neuronal excitability, resting membrane potential, and cellular responses to various stimuli. TREK1-expressing [neurons](/entities/neurons) are widely distributed throughout the central and peripheral nervous systems and play critical roles in neuroprotection, pain transduction, mood regulation, and responses to metabolic stress. This page provides comprehensive coverage of TREK1 neurons in normal function and neurodegeneration. [@bagriantsev2011]
Overview
Mermaid diagram (expand to render)
Structure and Gating
Channel Architecture
TREK1 is a K2P channel with unique structural features:
- Four transmembrane domains: M1-M4
- Two pore domains (P1 and P2): Form the potassium selectivity filter
- Two extracellular loops: Between M1-P1 and M3-P2
- N- and C-termini: Located intracellularly
Gating Mechanisms
TREK1 is uniquely regulated by multiple stimuli:
The channel has a large regulatory domain in the C-terminus that responds to mechanical, thermal, and chemical stimuli^[1].
Normal Function
Membrane Excitability
TREK1 provides background potassium conductance that:
- Stabilizes resting membrane potential near K+ equilibrium potential
- Sets input resistance and influences synaptic integration
- Modulates action potential threshold
- Provides dampening during repetitive firing
In cortical pyramidal neurons, TREK1 accounts for ~20% of the resting leak conductance^[2].
Neuroprotection
TREK1 plays a critical neuroprotective role:
- Ischemic preconditioning: Activated during oxygen-glucose deprivation
- Excitotoxicity: Reduces glutamate-induced neuronal death
- Oxidative stress: Protects against [ROS](/entities/reactive-oxygen-species)-mediated damage
- Metabolic stress: Couples cellular energy status to excitability
The channel is upregulated in neurons following ischemic preconditioning, and genetic deletion of TREK1 increases infarct size in stroke models^[3].
Pain Transduction
In dorsal root ganglion (DRG) neurons:
- Mechanosensation: TREK1/TRAAK detect mechanical stimuli
- Nociception: Modulates pain sensitivity
- Thermal sensation: Responds to temperature changes
TREK1 is downregulated in chronic pain states, contributing to hyperexcitability.
Psychiatric Disorders
- Depression: TREK1 polymorphisms associated with major depressive disorder
- Anxiety: Anxiolytic effects of TREK1 activation
- Anesthesia: Target for volatile anesthetic agents
Role in Neurodegeneration
Stroke and Ischemia
TREK1 is a critical mediator of ischemic neuroprotection:
- Preconditioning: Brief ischemia activates TREK1, providing tolerance
- Excitotoxicity: Reduces Ca2+ influx through NMDA receptors
- [Blood-brain barrier](/entities/blood-brain-barrier): Protects endothelial function
KCNK2 knockout mice show increased neuronal death after focal ischemia, while TREK1 activators are protective^[4].
Alzheimer's Disease
TREK1 alterations in AD include:
- [Amyloid-beta](/proteins/amyloid-beta) effects: Aβ reduces TREK1 current amplitude
- Neuronal hyperexcitability: Contributes to network dysfunction
- Calcium dysregulation: Indirect effects on calcium homeostasis
TREK1 dysfunction may contribute to the hyperexcitability observed in early AD.
Parkinson's Disease
In PD models:
- Dopaminergic neuron vulnerability: TREK1 expression altered in substantia nigra
- Mitochondrial toxins: MPTP affects TREK1 function
- Therapeutic potential: TREK1 activators may protect dopaminergic neurons
Epilepsy
TREK1 regulates neuronal excitability in epilepsy:
- Seizure threshold: TREK1 loss-of-function lowers threshold
- Status epilepticus: Altered expression following seizures
- Therapeutic targeting: TREK1 activators as anticonvulsants
Amyotrophic Lateral Sclerosis
- Motor neuron excitability: TREK1 contributes to hyperexcitability
- Cortical involvement: Altered in upper motor neurons
- Glial regulation: Astrocytic TREK1 affects neuronal support
Therapeutic Implications
Drug Development
Several approaches target TREK1:
Challenges
- Blood-brain barrier penetration: Key challenge for CNS drugs
- Selectivity: Developing selective activators
- Ion homeostasis: Balancing excitation/inhibition
Interactions and Signaling
TREK1 interacts with multiple proteins:
- KCNK4 (TRAAK): Co-expressed, complementary functions
- PSD-95: Synaptic localization
- Annexin A2: Mechanical coupling
- PIP2: Membrane phospholipid regulation
- Mecamylamine: Pharmacological modulation
Research Methods
- Patch clamp: Direct current recording
- FLIPR: High-throughput calcium screening
- CRISPR: Genetic manipulation
- Stroke models: MCAO in rodents
Key Publications
Honore E, et al. (2002). "The neuronal background of two-pore domain potassium channels." Neuropharmacology. PMID: 12126619(https://pubmed.ncbi.nlm.nih.gov/12126619/).
Talley EM, et al. (2001). "Distribution of neuronal members of the K2P channel family." J Comp Neurol. PMID: 11464962(https://pubmed.ncbi.nlm.nih.gov/11464962/).
Heurteaux C, et al. (2004). "TREK-1, a K+ channel involved in neuroprotection and general anesthesia." EMBO J. PMID: 15226251(https://pubmed.ncbi.nlm.nih.gov/15226251/).
Wu X, et al. (2019). "TREK1 channel mediates neuroprotection in stroke." J Cereb Blood Flow Metab. PMID: 30296824(https://pubmed.ncbi.nlm.nih.gov/30296824/).
Lotshaw DP. (2007). "Biophysical and pharmacological characterization of TASK-1 and TREK-1." Am J Physiol. PMID: 17209163(https://pubmed.ncbi.nlm.nih.gov/17209163/).See Also
- [KCNK2 Gene](/genes/kcnk2)
- [Two-Pore Domain Potassium Channels](/mechanisms/two-pore-domain-potassium-channels)
- [Stroke Mechanisms](/mechanisms/stroke-mechanisms)
- [Potassium Channels](/mechanisms/potassium-channels)
- [Ischemic Preconditioning](/mechanisms/ischemic-preconditioning)
- [Neuronal Excitability](/mechanisms/neuronal-excitability)
- [Dorsal Root Ganglion Neurons](/cell-types/dorsal-root-ganglion-neurons)
- [Cortical Pyramidal Neurons](/cell-types/cortical-pyramidal-neurons)
External Links
- [UniProt: TREK1 (KCNK2)](https://www.uniprot.org/uniprot/O95069)
- [NCBI Gene: KCNK2](https://www.ncbi.nlm.nih.gov/gene/3776)
- [IUPHAR: K2P Channels](https://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=36)
- [Allen Brain Atlas: KCNK2](https://brain-map.org/)
Background
The study of Trek1 Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Pathway Diagram
The following diagram shows the key molecular relationships involving TREK1 Neurons discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)